These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22735831)

  • 1. Effect of the NMDA antagonist MK-801 on latent inhibition of fear conditioning.
    Traverso LM; Ruiz G; De la Casa LG
    Pharmacol Biochem Behav; 2012 Oct; 102(4):488-94. PubMed ID: 22735831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
    Gaisler-Salomon I; Weiner I
    Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent inhibition of cued fear conditioning: an NMDA receptor-dependent process that can be established in the presence of anisomycin.
    Lewis MC; Gould TJ
    Eur J Neurosci; 2004 Aug; 20(3):818-26. PubMed ID: 15255992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dorsal hippocampus and classical fear conditioning to tone and context in rats: effects of local NMDA-receptor blockade and stimulation.
    Bast T; Zhang WN; Feldon J
    Hippocampus; 2003; 13(6):657-75. PubMed ID: 12962312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent inhibition disruption by MK-801 in a conditioned taste-aversion paradigm.
    Traverso LM; Ruiz G; De la Casa LG
    Neurobiol Learn Mem; 2003 Sep; 80(2):140-6. PubMed ID: 12932429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent inhibition in rats neonatally treated chronically with MK-801: differential effects on conditioned taste aversion and conditioned emotional response.
    Niikura R; Nozawa T; Yamada K; Kato K; Ichitani Y
    Behav Brain Res; 2015 Apr; 283():102-7. PubMed ID: 25629943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between glutamatergic-NMDA and cholinergic-muscarinic systems in classical fear conditioning.
    Figueredo LZ; Moreira KM; Ferreira TL; Fornari RV; Oliveira MG
    Brain Res Bull; 2008 Sep; 77(2-3):71-6. PubMed ID: 18582541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NMDA receptor antagonist MK-801 blocks acquisition and extinction of conditioned hypoalgesic responses in the rat.
    Cox J; Westbrook RF
    Q J Exp Psychol B; 1994 May; 47(2):187-210. PubMed ID: 8052728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. US habituation, like CS extinction, produces a decrement in conditioned fear responding that is NMDA dependent and subject to renewal and reinstatement.
    Storsve AB; McNally GP; Richardson R
    Neurobiol Learn Mem; 2010 May; 93(4):463-71. PubMed ID: 20074653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMDA receptor antagonism disrupts acquisition and retention of the context preexposure facilitation effect in adolescent rats.
    Heroux NA; Robinson-Drummer PA; Rosen JB; Stanton ME
    Behav Brain Res; 2016 Mar; 301():168-77. PubMed ID: 26711910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditioned stimulus familiarity determines effects of MK-801 on fear extinction.
    Chan WY; McNally GP
    Behav Neurosci; 2009 Apr; 123(2):303-14. PubMed ID: 19331454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the NMDA receptor antagonist MK-801 on the acquisition and extinction of learned fear in the developing rat.
    Langton JM; Kim JH; Nicholas J; Richardson R
    Learn Mem; 2007 Oct; 14(10):665-8. PubMed ID: 17909101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extinction in preweanling rats does not involve NMDA receptors.
    Kim JH; Richardson R
    Neurobiol Learn Mem; 2010 Sep; 94(2):176-82. PubMed ID: 20472087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rewarding properties of non-competitive and competitive NMDA antagonists as measured by place preference conditioning in rats.
    Papp M; Moryl E
    Pol J Pharmacol; 1994; 46(1-2):79-81. PubMed ID: 7981776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ventral hippocampus and fear conditioning in rats: different anterograde amnesias of fear after infusion of N-methyl-D-aspartate or its noncompetitive antagonist MK-801 into the ventral hippocampus.
    Zhang WN; Bast T; Feldon J
    Behav Brain Res; 2001 Nov; 126(1-2):159-74. PubMed ID: 11704261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA receptor modulation of incidental learning in Pavlovian context conditioning.
    Stote DL; Fanselow MS
    Behav Neurosci; 2004 Feb; 118(1):253-7. PubMed ID: 14979804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MK-801 disrupts acquisition of contextual fear conditioning but enhances memory consolidation of cued fear conditioning.
    Gould TJ; McCarthy MM; Keith RA
    Behav Pharmacol; 2002 Jul; 13(4):287-94. PubMed ID: 12218509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal transduction mechanisms within the entorhinal cortex that support latent inhibition of cued fear conditioning.
    Lewis MC; Gould TJ
    Neurobiol Learn Mem; 2007 Oct; 88(3):359-68. PubMed ID: 17560814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-order fear conditioning prevented by blocking NMDA receptors in amygdala.
    Gewirtz JC; Davis M
    Nature; 1997 Jul; 388(6641):471-4. PubMed ID: 9242405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic administration of MK-801, a non-competitive NMDA-receptor antagonist, elicits a behavioural deficit of rats in the Active Allothetic Place Avoidance (AAPA) task irrespectively of their intact spatial pretraining.
    Stuchlík A; Vales K
    Behav Brain Res; 2005 Apr; 159(1):163-71. PubMed ID: 15795010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.